Status:
COMPLETED
A Study to Evaluate Inhibition of Ovulation of Two Oral Estrogen/Progestogen Regimens in Healthy, Young Females Over a Period of 3 Treatment Cycles
Lead Sponsor:
Bayer
Conditions:
Contraception
Eligibility:
FEMALE
18-35 years
Phase:
PHASE2
Brief Summary
Investigation of a new pill containing an estrogen and a progestin in order to monitor the inhibition of the ovulation in young healthy females over 3 treatment cycles
Eligibility Criteria
Inclusion
- Healthy female volunteers,
- Age 18 - 35 years
Exclusion
- Contraindications for use of a combined (estrogen/progestogen) contraceptive (e.g. history of venous/arterial thromboembolic disease)
- Regular intake of medication
- Clinically relevant findings (ECG, blood pressure, physical, gynecological examination, laboratory examination)
- Anovulatory pre-treatment cycle
Key Trial Info
Start Date :
February 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
103 Patients enrolled
Trial Details
Trial ID
NCT00631124
Start Date
February 1 2008
End Date
December 1 2008
Last Update
December 2 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Berlin, State of Berlin, Germany, 10115
2
Berlin, State of Berlin, Germany, 13353